A Phase Ib Study of Belinostat With RDHAP Chemotherapy (Dexamethasone, Cytarabine, Cisplatinum) in Adults With Relapsed or Refractory Diffuse Large B-cell Lymphoma

Trial Profile

A Phase Ib Study of Belinostat With RDHAP Chemotherapy (Dexamethasone, Cytarabine, Cisplatinum) in Adults With Relapsed or Refractory Diffuse Large B-cell Lymphoma

Withdrawn prior to enrolment
Phase of Trial: Phase I

Latest Information Update: 29 Jan 2016

At a glance

  • Drugs Belinostat (Primary) ; Ciprofloxacin; Cisplatin; Cytarabine; Dexamethasone; Fluconazole; Rituximab
  • Indications Diffuse large B cell lymphoma
  • Focus Adverse reactions
  • Most Recent Events

    • 12 Jan 2016 Status changed from not yet recruiting to withdrawn prior to enrolment as per ClinicalTrials.gov record
    • 25 Sep 2015 Planned primary completion date changed from 1 Nov 2019 to 1 Dec 2019, as reported by ClinicalTrials.gov.
    • 25 Sep 2015 Planned initiation date changed from 1 Nov 2015 to 1 Dec 2015, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top